Open AccessAdvances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report
Author(s) -
J.Q. Del Rosso,
April W. Armstrong,
Brian Berman,
Neal Bhatia,
Clay J. Cockerell,
Gary Goldenberg,
Joslyn S. Kirby,
Mark Lebwohl,
Linda Stein Gold,
Justin W. Marson,
Darrell S. Rigel
Publication year - 2021
Publication title -
journal of drugs in dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 62
ISSN - 1545-9616
DOI - 10.36849/jdd.6078
Subject(s) - medicine , actinic keratosis , dermatology , medline , pathology , basal cell , political science , law
Actinic Keratosis (AK) is a potentially pre-malignant tumor with a poorly defined risk of progression to invasive squamous cell carcinoma (SCC). Because of the typical need for recurrent cycles of AK treatment, outcomes can be limited by both therapeutic efficacy and patient adherence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom